PL3117828T3 - Sposób namnażania komórek i środek farmaceutyczny do naprawy i regeneracji tkanek - Google Patents
Sposób namnażania komórek i środek farmaceutyczny do naprawy i regeneracji tkanekInfo
- Publication number
- PL3117828T3 PL3117828T3 PL16182980T PL16182980T PL3117828T3 PL 3117828 T3 PL3117828 T3 PL 3117828T3 PL 16182980 T PL16182980 T PL 16182980T PL 16182980 T PL16182980 T PL 16182980T PL 3117828 T3 PL3117828 T3 PL 3117828T3
- Authority
- PL
- Poland
- Prior art keywords
- regeneration
- repair
- tissue
- cell proliferation
- pharmaceutical agent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0278—Physical preservation processes
- A01N1/0284—Temperature processes, i.e. using a designated change in temperature over time
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/16—Blood plasma; Blood serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0679—Cells of the gastro-intestinal tract
- C12N5/068—Stem cells; Progenitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/60—Buffer, e.g. pH regulation, osmotic pressure
- C12N2500/62—DMSO
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/70—Undefined extracts
- C12N2500/80—Undefined extracts from animals
- C12N2500/84—Undefined extracts from animals from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/90—Polysaccharides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/90—Polysaccharides
- C12N2501/91—Heparin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Obesity (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Environmental Sciences (AREA)
- Dentistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007235436A JP2009065854A (ja) | 2007-09-11 | 2007-09-11 | 細胞増殖方法ならびに組織の修復および再生のための医薬 |
JP2007236499A JP2009065884A (ja) | 2007-09-12 | 2007-09-12 | 細胞増殖方法ならびに組織の修復および再生のための医薬 |
JP2007267211 | 2007-10-12 | ||
JP2007278083A JP2009100719A (ja) | 2007-10-25 | 2007-10-25 | 改善された増殖能を有する細胞およびその評価方法 |
JP2007278049A JP2009107929A (ja) | 2007-10-12 | 2007-10-25 | 損傷部位の修復を幇助する非経口全身投与剤 |
EP08830989.3A EP2194121B1 (en) | 2007-09-11 | 2008-09-10 | Cell growth method and pharmaceutical preparation for tissue repair and regeneration |
PCT/JP2008/002503 WO2009034708A1 (ja) | 2007-09-11 | 2008-09-10 | 細胞増殖方法ならびに組織の修復および再生のための医薬 |
EP16182980.9A EP3117828B1 (en) | 2007-09-11 | 2008-09-10 | Cell proliferation method, and pharmaceutical agent for repair and regeneration of tissue |
Publications (1)
Publication Number | Publication Date |
---|---|
PL3117828T3 true PL3117828T3 (pl) | 2020-05-18 |
Family
ID=42113874
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL08830989T PL2194121T3 (pl) | 2007-09-11 | 2008-09-10 | Sposób hodowania komórek i preparat farmaceutyczny do naprawy i regeneracji tkanek |
PL16182980T PL3117828T3 (pl) | 2007-09-11 | 2008-09-10 | Sposób namnażania komórek i środek farmaceutyczny do naprawy i regeneracji tkanek |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL08830989T PL2194121T3 (pl) | 2007-09-11 | 2008-09-10 | Sposób hodowania komórek i preparat farmaceutyczny do naprawy i regeneracji tkanek |
Country Status (12)
Country | Link |
---|---|
US (3) | US9700582B2 (pl) |
EP (2) | EP3117828B1 (pl) |
JP (1) | JP4936341B2 (pl) |
KR (3) | KR20160005140A (pl) |
CN (1) | CN101802174B (pl) |
AU (1) | AU2008298816B2 (pl) |
CA (1) | CA2699236C (pl) |
DK (2) | DK3117828T3 (pl) |
ES (2) | ES2776408T3 (pl) |
PL (2) | PL2194121T3 (pl) |
PT (2) | PT2194121T (pl) |
WO (1) | WO2009034708A1 (pl) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3117828B1 (en) * | 2007-09-11 | 2020-02-12 | Sapporo Medical University | Cell proliferation method, and pharmaceutical agent for repair and regeneration of tissue |
JP5185470B2 (ja) * | 2010-08-03 | 2013-04-17 | 北海道公立大学法人 札幌医科大学 | 自己血清添加骨髄細胞培養システム、自己血清添加骨髄細胞培養方法および自己血清添加培養骨髄細胞を有効成分とする医薬組成物の製造方法 |
US10016458B2 (en) | 2012-04-16 | 2018-07-10 | Baystate Health, Inc. | p53 silenced endothelial progenitor cells for diabetes |
CN107362357B (zh) | 2013-02-06 | 2021-04-27 | Nc医学研究公司 | 用于治疗神经变性的细胞疗法 |
CA2960268C (en) * | 2013-09-05 | 2024-01-09 | The Regents Of The University Of California | Adipose-derived mesenchymal stem cells for feline stomatitis treatment |
CN105566460B (zh) * | 2016-01-19 | 2018-11-23 | 南通大学 | 抑制肿瘤细胞增殖的多肽类似物和对应的编码cDNA及应用 |
JP6781973B2 (ja) * | 2016-01-29 | 2020-11-11 | 学校法人東京女子医科大学 | 腎臓病進行抑制細胞シート組成物、その製造方法、及び、それを用いた腎臓病進行抑制方法 |
US11666601B2 (en) | 2016-04-28 | 2023-06-06 | Sapporo Medical University | Synapse formation agent |
CN106153919B (zh) * | 2016-06-16 | 2018-06-29 | 汕头大学医学院 | CD105,esVEGR2和MYC三蛋白联合预测食管鳞癌患者预后试剂盒 |
WO2018034023A1 (ja) * | 2016-08-18 | 2018-02-22 | 北海道公立大学法人札幌医科大学 | 寿命延長剤 |
JP7076709B2 (ja) * | 2016-08-18 | 2022-05-30 | 北海道公立大学法人 札幌医科大学 | 間葉系幹細胞活性化剤 |
JP7089283B2 (ja) | 2016-08-30 | 2022-06-22 | 国立大学法人 新潟大学 | 細胞製剤および細胞製剤の製造方法 |
US11542473B2 (en) | 2016-10-21 | 2023-01-03 | Amniotics Ab | Methods and compositions for generating hematopoietic cells |
JP6438527B2 (ja) * | 2017-06-01 | 2018-12-12 | Ncメディカルリサーチ株式会社 | 神経変性の治療のための細胞療法 |
CN109517789B (zh) * | 2017-09-19 | 2022-05-27 | 北京大学 | Ghrelin活性剂用于诱导干细胞向软骨细胞分化 |
CA3082368A1 (en) | 2017-11-09 | 2019-05-16 | Sapporo Medical University | Medicine for tissue regeneration, and preparation method therefor |
CN108535479B (zh) * | 2018-04-04 | 2019-04-19 | 首都医科大学附属北京地坛医院 | sCD163检测试剂在梅毒检测中的应用及包括该试剂的试剂盒 |
CN112004922A (zh) * | 2018-04-25 | 2020-11-27 | 北海道公立大学法人札幌医科大学 | 生物移植用细胞片及其制造方法 |
CN110870917B (zh) * | 2018-09-03 | 2022-03-15 | 上海市第一人民医院 | Ews或其上调剂在制备治疗糖尿病及防治糖尿病个体肿瘤发生的药物中的应用 |
SG11202108656UA (en) | 2019-02-07 | 2021-09-29 | Univ Sapporo Medical | Pharmaceutical composition for preventing in-stent restenosis |
SG11202110033UA (en) | 2019-03-14 | 2021-10-28 | Univ Sapporo Medical | Pharmaceutical composition for treating amyotrophic lateral sclerosis |
WO2021076043A1 (en) | 2019-10-18 | 2021-04-22 | Amniotics Ab | Use of term amniotic fluid cells for the treatment of acute and chronic respiratory diseases |
CN112899223A (zh) * | 2019-12-04 | 2021-06-04 | 陕西光子动力航天科技有限公司 | 宫血干细胞制备方法 |
WO2021132662A1 (ja) * | 2019-12-27 | 2021-07-01 | 北海道公立大学法人 札幌医科大学 | 哺乳動物細胞を培養するための血清の製造方法 |
CA3172745A1 (en) | 2020-03-31 | 2021-10-07 | Yasutomo YANAGITA | Cell preservation method |
US20230302055A1 (en) * | 2020-09-03 | 2023-09-28 | Two Cells Co., Ltd. | Composition for treating central nervous system diseases, method for producing composition for treating central nervous system diseases, and method for producing therapeutic formulation for central nervous system diseases |
CN112826920A (zh) * | 2021-01-23 | 2021-05-25 | 中国人民解放军陆军军医大学 | Id1/id3在诱导成纤维细胞重编程为施万细胞促进神经再生的应用 |
CN113652491A (zh) * | 2021-02-02 | 2021-11-16 | 暨南大学 | m6A RNA甲基化含量及其甲基化相关酶和结合蛋白在制备衰老检测试剂盒中的应用 |
US20230075134A1 (en) | 2021-08-31 | 2023-03-09 | Joshua Medical Holdings Co. Ltd. | Method for isolating and purifying mesenchymal stem cells from hernia sac and method for tissue repair by using mesenchymal stem cells from hernia sac |
CN114164216B (zh) * | 2021-12-21 | 2023-08-25 | 北京航空航天大学 | 一种基因在促进骨形成中的应用 |
Family Cites Families (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4038139A (en) * | 1976-07-16 | 1977-07-26 | G. D. Searle & Co., Limited | Cell culture medium |
US5486359A (en) * | 1990-11-16 | 1996-01-23 | Osiris Therapeutics, Inc. | Human mesenchymal stem cells |
US5736396A (en) * | 1995-01-24 | 1998-04-07 | Case Western Reserve University | Lineage-directed induction of human mesenchymal stem cell differentiation |
JP3211941B2 (ja) | 1996-12-26 | 2001-09-25 | 科学技術振興事業団 | ヒト小型肝細胞の取得方法と、この細胞の初代培養および継代培養方法 |
US6335195B1 (en) * | 1997-01-28 | 2002-01-01 | Maret Corporation | Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation |
US5968829A (en) | 1997-09-05 | 1999-10-19 | Cytotherapeutics, Inc. | Human CNS neural stem cells |
TR200401091T4 (tr) | 1999-12-28 | 2004-06-21 | Iso Tis N.V. | Gelişim faktörleri ve L-glutamin içeren hücre kültürü besiyeri |
EP2295539A1 (en) | 2000-06-26 | 2011-03-16 | Nc Medical Research Inc. | Cell fractions containing cells capable of differentiating into neural cells |
JP2003052360A (ja) | 2001-08-20 | 2003-02-25 | Japan Science & Technology Corp | 基底膜細胞外基質を用いた間葉系幹細胞の培養方法 |
WO2003038075A1 (fr) | 2001-10-30 | 2003-05-08 | Renomedix Institute Inc. | Procede permettant d'induire une differenciation de cellules souches embroyonnaires mesodermiques, de cellules es ou de cellules immortalisees dans des cellules du systeme nerveux |
JP2003235548A (ja) | 2001-12-13 | 2003-08-26 | Japan Science & Technology Corp | ヒト細胞の培養用培地および培養方法 |
ES2198216B1 (es) * | 2002-07-02 | 2005-04-16 | Juan Carlos Instituto Cientifico Y Tecnologico De Navarra, S.A.(67%). | Medio de cultivo de celulas madre-progenitoras autologas humanas y sus aplicaciones. |
JPWO2004076652A1 (ja) * | 2003-02-25 | 2006-06-08 | 学校法人東海大学 | 椎間板再生用の幹細胞用培地及び幹細胞を用いた椎間板の再生 |
JPWO2005007176A1 (ja) | 2003-06-27 | 2006-08-31 | 株式会社レノメディクス研究所 | 間葉系細胞を有効成分とする体内投与用脳神経疾患治療薬 |
US20060210544A1 (en) * | 2003-06-27 | 2006-09-21 | Renomedix Institute, Inc. | Internally administered therapeutic agents for cranial nerve diseases comprising mesenchymal cells as an active ingredient |
KR101100658B1 (ko) | 2003-06-27 | 2012-01-03 | 엔씨 메디컬 리서치 가부시키가이샤 | 치료용 자기 세포의 배송 지원 시스템 및 그 방법 |
US20070178591A1 (en) * | 2004-06-25 | 2007-08-02 | Renomedix Institute, Inc | Internally administered therapeutic agents for diseases in central and peripheral nervous system comprising mesenchymal cells as an active ingredient |
CN1590537A (zh) * | 2003-09-02 | 2005-03-09 | 中国人民解放军第四军医大学口腔医学院 | 外胚间充质干细胞的分离和培养方法 |
JP4651282B2 (ja) | 2004-01-21 | 2011-03-16 | 田辺三菱製薬株式会社 | 造血幹細胞及び造血前駆細胞の増幅方法 |
JP4597538B2 (ja) | 2004-02-03 | 2010-12-15 | 独立行政法人産業技術総合研究所 | 神経幹細胞増殖助剤及びこれを含んだ神経幹細胞用培地 |
JP2006034118A (ja) * | 2004-07-23 | 2006-02-09 | Kaneka Corp | 間葉系幹細胞の効率的保存または調製方法 |
JP2006055106A (ja) * | 2004-08-23 | 2006-03-02 | National Institute Of Advanced Industrial & Technology | ヒト血清培地を用いるヒト骨髄由来間葉系幹細胞培養法 |
JP2006136281A (ja) | 2004-11-15 | 2006-06-01 | Olympus Corp | 培地および間葉系幹細胞の培養方法 |
EP1820852A4 (en) | 2004-11-19 | 2007-11-14 | Jms Co Ltd | HUMAN SERUM FOR CELL CULTURE |
CN1699557A (zh) * | 2005-05-26 | 2005-11-23 | 南开大学 | 一种骨髓间充质干细胞的分离及培养方法 |
US20070047270A1 (en) | 2005-09-01 | 2007-03-01 | Creative Technology Ltd. | Load detector for an AC-AC power supply |
WO2007027156A1 (en) * | 2005-09-02 | 2007-03-08 | Agency For Science, Technology And Research | Method of deriving mesenchymal stem cells |
JP2007235436A (ja) | 2006-02-28 | 2007-09-13 | Sunx Ltd | 電子回路及び光電センサ |
JP5170967B2 (ja) | 2006-03-06 | 2013-03-27 | 株式会社大一商会 | 遊技機 |
JP4719604B2 (ja) | 2006-03-29 | 2011-07-06 | エヌ・ティ・ティ アイティ株式会社 | コマーシャル検出方法およびコマーシャル検出装置並びにコマーシャル検出プログラムが記録された記録媒体 |
JP4779775B2 (ja) | 2006-04-03 | 2011-09-28 | 日産自動車株式会社 | 内燃機関の吸気制御装置 |
JP2007278049A (ja) | 2006-04-07 | 2007-10-25 | Voice Interface:Kk | 凝固剤注入によるアスベスト封じ込めシステム |
EP3117828B1 (en) * | 2007-09-11 | 2020-02-12 | Sapporo Medical University | Cell proliferation method, and pharmaceutical agent for repair and regeneration of tissue |
-
2008
- 2008-09-10 EP EP16182980.9A patent/EP3117828B1/en active Active
- 2008-09-10 DK DK16182980.9T patent/DK3117828T3/da active
- 2008-09-10 CA CA2699236A patent/CA2699236C/en active Active
- 2008-09-10 AU AU2008298816A patent/AU2008298816B2/en active Active
- 2008-09-10 JP JP2009532060A patent/JP4936341B2/ja active Active
- 2008-09-10 CN CN2008801065843A patent/CN101802174B/zh active Active
- 2008-09-10 KR KR1020157036694A patent/KR20160005140A/ko not_active Application Discontinuation
- 2008-09-10 KR KR1020107007607A patent/KR101614823B1/ko active IP Right Grant
- 2008-09-10 PL PL08830989T patent/PL2194121T3/pl unknown
- 2008-09-10 PL PL16182980T patent/PL3117828T3/pl unknown
- 2008-09-10 WO PCT/JP2008/002503 patent/WO2009034708A1/ja active Application Filing
- 2008-09-10 DK DK08830989.3T patent/DK2194121T3/en active
- 2008-09-10 US US12/677,610 patent/US9700582B2/en active Active
- 2008-09-10 ES ES16182980T patent/ES2776408T3/es active Active
- 2008-09-10 PT PT88309893T patent/PT2194121T/pt unknown
- 2008-09-10 ES ES08830989.3T patent/ES2611021T3/es active Active
- 2008-09-10 PT PT161829809T patent/PT3117828T/pt unknown
- 2008-09-10 KR KR1020177027585A patent/KR102087366B1/ko active IP Right Grant
- 2008-09-10 EP EP08830989.3A patent/EP2194121B1/en active Active
-
2017
- 2017-06-08 US US15/617,571 patent/US10328102B2/en active Active
-
2019
- 2019-05-06 US US16/404,671 patent/US11426432B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
ES2776408T3 (es) | 2020-07-30 |
JP4936341B2 (ja) | 2012-05-23 |
CN101802174B (zh) | 2013-06-05 |
CA2699236C (en) | 2017-02-28 |
DK2194121T3 (en) | 2016-12-12 |
EP2194121B1 (en) | 2016-10-26 |
CN101802174A (zh) | 2010-08-11 |
PT2194121T (pt) | 2016-12-05 |
US11426432B2 (en) | 2022-08-30 |
PL2194121T3 (pl) | 2017-02-28 |
PT3117828T (pt) | 2020-03-17 |
ES2611021T3 (es) | 2017-05-04 |
US10328102B2 (en) | 2019-06-25 |
WO2009034708A1 (ja) | 2009-03-19 |
KR20160005140A (ko) | 2016-01-13 |
KR20170116219A (ko) | 2017-10-18 |
KR20100072240A (ko) | 2010-06-30 |
US20170266234A1 (en) | 2017-09-21 |
AU2008298816B2 (en) | 2013-09-26 |
EP2194121A4 (en) | 2012-03-07 |
EP2194121A1 (en) | 2010-06-09 |
JPWO2009034708A1 (ja) | 2010-12-24 |
US9700582B2 (en) | 2017-07-11 |
US20190255118A1 (en) | 2019-08-22 |
KR102087366B1 (ko) | 2020-03-10 |
CA2699236A1 (en) | 2009-03-19 |
US20100254953A1 (en) | 2010-10-07 |
EP3117828B1 (en) | 2020-02-12 |
KR101614823B1 (ko) | 2016-04-22 |
AU2008298816A1 (en) | 2009-03-19 |
DK3117828T3 (da) | 2020-03-09 |
EP3117828A1 (en) | 2017-01-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT3117828T (pt) | Método de proliferação celular, e agente farmacêutico para reparação e regeneração de tecidos | |
HK1216040A1 (zh) | 評估組織的系統和方法 | |
IL209513A0 (en) | Methods, compositions and apparatus for facilitating regeneration | |
EP2334262A4 (en) | SYSTEM AND METHOD FOR REALIZING VERTEBRAL SURGERY | |
EP2273945A4 (en) | METHOD AND SYSTEM FOR CRYOABLATION TREATMENT | |
IL210754A0 (en) | Devices, methods, and kits for forming tracts in tissue | |
EP2170182A4 (en) | METHODS AND SYSTEMS FOR PRACTICING SUB-MUCOUS DOSAGE ACTIONS | |
EP1991150A4 (en) | METHOD AND DEVICE FOR SURGICAL ELECTROCAUTERISATION | |
EP2132529A4 (en) | SYSTEM AND METHOD FOR EFFICIENTLY PERFORMING IMPROVED MOBILE DEVICE LOCATION PROCEDURES | |
EP2384221A4 (en) | METHOD FOR REDUCING COMPLAINTS DURING ELECTROSTIMULATION AND COMPOSITIONS AND DEVICE THEREFOR | |
IL205778A0 (en) | Medical system, apparatus and method | |
IL205777A0 (en) | Medical system, apparatus and method | |
EP2306928A4 (en) | METHOD, APPARATUS AND SYSTEM FOR USE IN DENTAL PROCEDURES | |
IL216263A0 (en) | Devices, methods and kits for forming tracts in tissue | |
IL199797A0 (en) | Methods and devices for heart tissue repair | |
IL205735A0 (en) | System and method for regenerating an absorbent solution | |
EP2293733A4 (en) | METHODS, SYSTEMS AND DEVICES FOR EXECUTING ELECTROSURGICAL PROCEDURES | |
EP2157166A4 (en) | MODEL CELL CHIP, APPARATUS FOR EVALUATING THE EFFECT OF A MEDICAMENT BY USING THE MODEL CELL CHIP AND METHOD OF EVALUATING THE EFFECT OF A MEDICAMENT | |
IL218780A0 (en) | Devices,, methods, and kits for forming tracts in tissue | |
EP2301560A4 (en) | PHARMACEUTICAL AGENT FOR PROMOTING THE FUNCTIONAL REGENERATION OF DEGRADED TISSUE | |
EP2165715A4 (en) | THERAPEUTIC AGENT FOR CANCER AND METHOD FOR TREATING CANCER | |
PT2491056T (pt) | Vhh para aplicação na reparação de tecidos, regeneração de órgãos, substituição de órgãos e engenharia de tecidos | |
EP2170549A4 (en) | SYSTEM, METHODS AND APPARATUS FOR COMPONENT REPAIR | |
HUP0700369D0 (en) | Pharmaceutical compositions and method for treating schizofrenia | |
EP2211851A4 (en) | LAMININS, DERIVATIVES, COMPOSITIONS CONTAINING SAME, AND METHOD FOR THEIR THERAPEUTIC USE |